Altre lingue Albert Labs International Corp. OTC Markets

Azioni

ALBLF

CA0127841041

Mercato chiuso - OTC Markets Altri mercati azionari			Variaz. 5gg	Var. 1 gen.
- ^USD	-.--%		-.--%	-.--%

2023	Albert Labs International Corp. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI
2023	Albert Labs International Corp. nomina Shabir Hasham nel suo Consiglio di Amministrazione	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Albert Labs International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
Albert Labs International Corp. Appoints Shabir Hasham to Its Board of Directors	18/10/23
Albert Labs International Corp. Announces Resignation of Michael Raymont as Board of Directors	05/09/23
Albert Labs International Corp. Announces CEO Changes	05/09/23
Albert Labs International Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/08/23
CSE Bulletin: Reinstatement - Albert Labs International Corp. (ABRT)	07/07/23
Canadian Investment Regulatory Organization Trade Resumption - ABRT	07/07/23
Albert Labs International Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	07/06/23
Albert Labs International Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	02/06/23
Albert Labs International Corp. Auditor Raises 'Going Concern' Doubt	02/06/23
CSE Bulletin: Suspensions - ADMT, ABRT, CFT, GAIA, IWIN, PKG, POLE, PRTI, RWB, CALM, RVR, VEJI	09/05/23
IIROC Trading Halt - ABRT	09/05/23
Albert Labs International Corp. Announces Preliminary Acceptance of 35 Novel Innovative Claims	02/05/23
Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology	02/05/23
Albert Labs announces Private Placement	24/04/23
Albert Labs International Corp. announced that it expects to receive CAD 3 million in funding	24/04/23
Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human Trials	28/03/23
Albert Labs International Corp. announced that it expects to receive CAD 0.83 million in funding from Cantheon Capital	23/03/23
Albert Labs Validates Global Supply Chain for Controlled Substances	15/03/23
Albert Labs International Corp. announced that it has received CAD 0.3 million in funding	24/02/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Albert Labs International Corp. OTC Markets

Azioni

ALBLF

CA0127841041

Altre lingue

Filtri